Dpression and breast cancer

Authors

  • Renata Demarque Psiquiatra, Instituto do Câncer do Estado de São Paulo, Instituto de Psiquiatria, Hospital das Clínicas da Universidade de São Paulo (HC-USP), São Paulo, SP.
  • Joel Rennó Junior Diretor
  • Hewdy Lobo Ribeiro Psiquiatra forense pela ABP/CFM.
  • Juliana Pires Cavalsan Psiquiatra forense pela ABP/CFM.
  • Gislene Valadares Ambulatório de Acolhimento e Tratamento de Famílias Incestuosas (AMEFI), Hospital das Clínicas da Universidade Federal de Minas Gerais (HC-UFMG), Belo Horizonte, MG.
  • Amaury Cantilino Professor, Departamento de Neuropsiquiatria, Universidade Federal de Pernambuco (UFPE), Recife, PE.
  • Jerônimo de Almeida Mendes Ribeiro Psiquiatra. Clinical Fellow, Women’s Mental Health, Universidade de McMaster, Canadá.
  • Renan Rocha Programa de Saúde Mental da Mulher, Núcleo de Prevenção às Violências e Promoção da Saúde (NUPREVIPS), Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC.
  • Antônio Geraldo da Silva Diretor Científico, Programa de Atualização em Psiquiatria (PROPSIQ), Sistema de Educação Continuada a Distância (SECAD). https://orcid.org/0000-0003-3423-7076

DOI:

https://doi.org/10.25118/2236-918X-6-1-4

Keywords:

Depression, depressive symptoms, cancer, antidepressants, oncopsychiatry

Abstract

Considering the large incidence of breast cancer in Brazil and the impact that diagnosis and treatment have in the lives of these women, psychiatrists have a very important role to play in this setting. A better adjustment to the disease, improved management of depression and improved adherence to treatment are some of the goals of oncopsychiatry.

 

Downloads

Download data is not yet available.

References

Veit MT, Carvalho V. Psico-oncologia: conceituação, definições, abrangência de campo. In: Carvalho VA, Franco MHP, Kovács MJ, Liberato RP, Macieira RC, Veit MT, et al. Temas em psico-oncologia. São Paulo: Summus; 2008. p. 15-20.

Graner KM, Cezar LTS, Teng CT. Transtornos do humor em psico-oncologia. In: Carvalho VA, Franco MHP, Kovács MJ, Liberato RP, Macieira RC, Veit MT, et al. Temas em psico-oncologia. São Paulo: Summus; 2008. p. 243-56.

Holland JC. Historical overview. In: Holland JC, Rowland JH. Handbook of psycho-oncology:psychological care of the pati ent with cancer. New York: Oxford University; 1989. p. 3-12.

Canti nelli FS, Camacho RS, Smaletz O, Gonsales BK, Braguitt oni E, Rennó J Jr. A oncopsiquiatria no câncer de mama - considerações a respeito de questões do feminino. Rev Psiquiatr Clin. 2006;33;124-33. https://doi.org/10.1590/S0101-60832006000300002

Barros ACSD. Câncer de mama. In: Carvalho VA, Franco MHP, Kovács MJ, Liberato RP, Macieira RC, Veit MT, et al. Temas em psico-oncologia. São Paulo: Summus; 2008. p. 40-5.

Henry NL, Stearns V, Flockhart DA, Hayes DF, Riba M. Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry. 2008;165:1251-5. https://doi.org/10.1176/appi.ajp.2008.08040482

Sheppard VB, Harper FW, Davis K, Hirpa F, Makambi K. The importance of contextual factors and age in associati on with anxiety and depression in Black breast cancer pati ents. Psychooncology. 2014;23:143-50. https://doi.org/10.1002/pon.3382

Sati n JR, Linden W, Philips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349-61. https://doi.org/10.1002/cncr.24561

Cronin-Fenton D, Lash TL, Sorensen HT. Selecti ve serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality. Future Oncol. 2010;6:877-80.

https://doi.org/10.2217/fon.10.65

Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunett a KL, Silliman RA, et al. Breast cancer recurrence risk related to concurrent use of SSRI anti depressants and tamoxifen. Acta Oncol. 2010;49;305-12. https://doi.org/10.3109/02841860903575273

Souza RDM, Marti ns DMF, Chein MBC, Brito LMO. Importância do CYP2D6 em usuárias de tamoxifeno no câncer de mama. Femina. 2011;39.

Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austi n PC, et al. Selecti ve serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a populati on based cohort study. BMJ. 2010;340:c693. https://doi.org/10.1136/bmj.c693

Caruso R, Grassi L, Nanni MG, Riba M. Psychopharmacology in psycho-oncology. Curr Psychiatry Rep. 2013;15:393. https://doi.org/10.1007/s11920-013-0393-0

Borges S, Desta Z, Li L, Skaar TC, Ward BA, Nguyen A, et al. Quanti tati ve eff ect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implicati on for opti mizati on of breast cancer treatment. Clin Pharmacol Ther. 2006;80:61-74. https://doi.org/10.1016/j.clpt.2006.03.013

Laouti dis ZG, Mathiak K. Anti depressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and metaanalysis. BMC Psychiatry. 2013;13:140. https://doi.org/10.1186/1471-244X-13-140

Downloads

Published

2016-02-29

How to Cite

1.
Demarque R, Rennó Junior J, Ribeiro HL, Cavalsan JP, Valadares G, Cantilino A, et al. Dpression and breast cancer. Debates em Psiquiatria [Internet]. 2016 Feb. 29 [cited 2025 Mar. 10];6(1):32-4. Available from: https://revistardp.org.br/revista/article/view/146

Conference Proceedings Volume

Vol. 6 No. 1 (2016)

Section

Update Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:

  • Share — copy and redistribute the material in any medium or format
  • Adapt — remix, transform, and build upon the material

The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Crossref
Scopus
Google Scholar
Europe PMC

Plaudit

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>